Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection
증상 및 무증상 SARS-CoV-2 감염에 대한 보호 상관관계
Article
[키워드] Alpha
analyzed
Anti-RBD antibodies
Anti-spike
antibody
antibody levels
Antibody Units
assays
asymptomatic infection
asymptomatic infections
AZD1222
B.1.1.7
binding
binding and neutralizing antibodies
binding antibody unit
binding antibody units
can be used
ChAdOx1
ChAdOx1 nCoV-19
correlated
COVID-19 vaccine
COVID-19 vaccines
determine
Efficacy
elicited
estimate
extrapolation
facilitate
immune marker
immune markers
immune response
Infectious diseases
International
international unit
majority
marker
neutralization
neutralization titer
neutralization titers
Neutralizing antibodies
neutralizing antibody
normalized
not correlated
Population
Predictive
pseudovirus
Randomized
recipients
reduced risk
SARS-CoV-2
SARS-COV-2 infection
second dose
significance level
symptomatic and asymptomatic
symptomatic infection
These data
Trial
United Kingdom
Vaccine
vaccine efficacy
Vaccines
variant of SARS-CoV-2
were measured
[DOI] 10.1038/s41591-021-01540-1 PMC 바로가기 [Article Type] Article
[DOI] 10.1038/s41591-021-01540-1 PMC 바로가기 [Article Type] Article